INS and type 2 diabetes mellitus: Real world data showed that withdrawal of pre-prandial insulin is feasible in about 50% of T2D patients, especially those with a better residual beta-cell function (younger, with shorter disease duration, lower HbA1c, and needing lower insulin doses) [51].